The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-2-(3-(4-(2-(4-(4-methoxyphenyl)piperazin-1-yl)-2-oxoethyl)phenyl)allyl)-1H-pyrrolo[3,4-b]quinolin-3(2H)-one ID: ALA2283031
PubChem CID: 76312753
Max Phase: Preclinical
Molecular Formula: C33H32N4O3
Molecular Weight: 532.64
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(N2CCN(C(=O)Cc3ccc(/C=C/CN4Cc5cc6ccccc6nc5C4=O)cc3)CC2)cc1
Standard InChI: InChI=1S/C33H32N4O3/c1-40-29-14-12-28(13-15-29)35-17-19-36(20-18-35)31(38)21-25-10-8-24(9-11-25)5-4-16-37-23-27-22-26-6-2-3-7-30(26)34-32(27)33(37)39/h2-15,22H,16-21,23H2,1H3/b5-4+
Standard InChI Key: PWZMAJPYZQGMHA-SNAWJCMRSA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
-4.1836 -6.0298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1824 -6.8494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4790 -7.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4772 -5.6210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7660 -6.0262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7668 -6.8453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0556 -7.2523 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0665 -5.6160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3558 -6.0194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3507 -6.8430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5667 -7.0946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0826 -6.4264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5699 -5.7620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3103 -7.8709 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7347 -6.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1460 -7.1295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9632 -7.1264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3744 -7.8325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9661 -8.5380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3767 -9.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1947 -9.2409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6005 -8.5267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1875 -7.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6070 -9.9465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4241 -9.9423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8291 -9.2326 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8364 -10.6479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4320 -11.3544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8408 -12.0579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6583 -12.0579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0654 -11.3482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6550 -10.6386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0678 -12.7607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6584 -13.4693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0673 -14.1759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8853 -14.1753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2928 -13.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8816 -12.7583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2958 -14.8819 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8891 -15.5907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 9 1 0
11 14 2 0
12 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 1 0
25 26 2 0
25 27 1 0
27 28 1 0
27 32 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 33 1 0
30 33 1 0
36 39 1 0
39 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 532.64Molecular Weight (Monoisotopic): 532.2474AlogP: 4.80#Rotatable Bonds: 7Polar Surface Area: 65.98Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.73CX Basic pKa: 3.99CX LogP: 4.76CX LogD: 4.76Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.34Np Likeness Score: -0.72
References 1. Nagarapua L, Gaikwad HK, Manikonda SR, Bantu R, Manda KM, Kalivendi SV. (2013) Synthesis of novel building blocks of 1H-pyrrolo[3,4-b]quinolin-3(2H)-one and evaluation of their antitumor activity, 22 (1): [10.1007/s00044-012-0018-x ]